Scales CD Jr, Smith AC, Hanley JM, Saigal CS. Urologic diseases in America P: prevalence of kidney stones in the United States. Eur Urol. 2012;62:160–5.
Article PubMed PubMed Central Google Scholar
Kittanamongkolchai W, Vaughan LE, Enders FT, Dhondup T, Mehta RA, Krambeck AE, McCollough CH, Vrtiska TJ, Lieske JC, Rule AD. The changing incidence and presentation of urinary stones over 3 decades. Mayo Clin Proc. 2018;93:291–9.
Sorokin I, Mamoulakis C, Miyazawa K, Rodgers A, Talati J, Lotan Y. Epidemiology of stone disease across the world. World J Urol. 2017;35:1301–20.
Lang J, Narendrula A, El-Zawahry A, Sindhwani P, Ekwenna O. Global trends in incidence and burden of urolithiasis from 1990 to 2019: an analysis of global burden of disease study data. Eur Urol Open Sci. 2022;35:37–46.
Article PubMed PubMed Central Google Scholar
Raja A, Hekmati Z, Joshi HB. How do urinary calculi influence health-related quality of life and patient treatment preference: a systematic review. J Endourol. 2016;30:727–43.
Hyams ES, Matlaga BR. Economic impact of urinary stones. Transl Androl Urol. 2014;3:278–83.
PubMed PubMed Central Google Scholar
Khan SR, Pearle MS, Robertson WG, Gambaro G, Canales BK, Doizi S, Traxer O, Tiselius HG. Kidney stones. Nat Rev Dis Primers. 2016;2:16008.
Article PubMed PubMed Central Google Scholar
Peerapen P, Thongboonkerd V. Kidney stone prevention. Adv Nutr. 2023;14:555–69.
Article CAS PubMed PubMed Central Google Scholar
Wong Y, Cook P, Roderick P, Somani BK. Metabolic syndrome and kidney Stone Disease: a systematic review of literature. J Endourol. 2016;30:246–53.
Moftakhar L, Jafari F, Ghoddusi Johari M, Rezaeianzadeh R, Hosseini SV, Rezaianzadeh A. Prevalence and risk factors of kidney stone disease in population aged 40–70 years old in Kharameh cohort study: a cross-sectional population-based study in southern Iran. BMC Urol. 2022;22:205.
Article PubMed PubMed Central Google Scholar
Goldfarb DS, Fischer ME, Keich Y, Goldberg J. A twin study of genetic and dietary influences on nephrolithiasis: a report from the Vietnam era Twin (VET) registry. Kidney Int. 2005;67:1053–61.
Brikowski TH, Lotan Y, Pearle MS. Climate-related increase in the prevalence of urolithiasis in the United States. Proc Natl Acad Sci U S A. 2008;105:9841–6.
Article CAS PubMed PubMed Central Google Scholar
Ferraro PM, Bargagli M, Trinchieri A, Gambaro G. Risk of kidney stones: influence of dietary factors, dietary patterns, and vegetarian-vegan diets. Nutrients. 2020;12:779.
Article CAS PubMed PubMed Central Google Scholar
Liu M, Wu J, Gao M, Li Y, Xia W, Zhang Y, Chen J, Chen Z, Zhu Z, Chen H. Lifestyle factors, serum parameters, metabolic comorbidities, and the risk of kidney stones: a mendelian randomization study. Front Endocrinol (Lausanne). 2023;14:1240171.
Soligo M, Morlacco A, Zattoni F, Valotto C, Beltrami GDEG. Metabolic syndrome and stone disease. Panminerva Med. 2022;64:344–58.
Torricelli FC, De SK, Gebreselassie S, Li I, Sarkissian C, Monga M. Dyslipidemia and kidney stone risk. J Urol. 2014;191:667–72.
Article CAS PubMed Google Scholar
Siener R. Nutrition and kidney Stone Disease. Nutrients. 2021;13:1917.
Article CAS PubMed PubMed Central Google Scholar
Khan SR, Glenton PA, Backov R, Talham DR. Presence of lipids in urine, crystals and stones: implications for the formation of kidney stones. Kidney Int. 2002;62:2062–72.
Article CAS PubMed Google Scholar
Howles SA, Thakker RV. Genetics of kidney stone disease. Nat Rev Urol. 2020;17:407–21.
Kim SW, Jee JH, Kim HJ, Jin SM, Suh S, Bae JC, Kim SW, Chung JH, Min YK, Lee MS, et al. Non-HDL-cholesterol/HDL-cholesterol is a better predictor of metabolic syndrome and insulin resistance than apolipoprotein B/apolipoprotein A1. Int J Cardiol. 2013;168:2678–83.
Lin W, Luo S, Li W, Liu J, Zhou T, Yang F, Zhou D, Liu Y, Huang W, Feng Y, Luo J. Association between the non-HDL-cholesterol to HDL- cholesterol ratio and abdominal aortic aneurysm from a Chinese screening program. Lipids Health Dis. 2023;22:187.
Article CAS PubMed PubMed Central Google Scholar
Qi X, Wang S, Huang Q, Chen X, Qiu L, Ouyang K, Chen Y. The association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) and risk of depression among US adults: a cross-sectional NHANES study. J Affect Disord. 2024;344:451–7.
Article CAS PubMed Google Scholar
Hou K, Song W, He J, Ma Z. The association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) and prevalence of periodontitis among US adults: a cross-sectional NHANES study. Sci Rep. 2024;14:5558.
Article CAS PubMed PubMed Central Google Scholar
Curhan GC, Willett WC, Rimm EB, Stampfer MJ. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med. 1993;328:833–8.
Article CAS PubMed Google Scholar
Hicks CW, Wang D, Matsushita K, Windham BG, Selvin E. Peripheral neuropathy and all-cause and cardiovascular mortality in U.S. adults: a prospective cohort study. Ann Intern Med. 2021;174:167–74.
Vasquez E, Batsis JA, Germain CM, Shaw BA. Impact of obesity and physical activity on functional outcomes in the elderly: data from NHANES 2005–2010. J Aging Health. 2014;26:1032–46.
Article PubMed PubMed Central Google Scholar
Hung JA, Li CH, Geng JH, Wu DW, Chen SC. Dyslipidemia increases the risk of incident kidney stone disease in a large Taiwanese population follow-up study. Nutrients. 2022;14:1339.
Article CAS PubMed PubMed Central Google Scholar
Tan Z, Hong J, Sun A, Ding M, Shen J. Causal effects of circulating lipids and lipid-lowering drugs on the risk of urinary stones: a mendelian randomization study. Front Endocrinol (Lausanne). 2023;14:1301163.
Bobulescu IA, Lotan Y, Zhang J, Rosenthal TR, Rogers JT, Adams-Huet B, Sakhaee K, Moe OW. Triglycerides in the human kidney cortex: relationship with body size. PLoS One. 2014;9:e101285.
Article PubMed PubMed Central Google Scholar
Cai C, Mai Z, Deng T, Zhao Z, Zhu W, Wen Y, Duan X, Wu W, Zeng G. Impact of dyslipidemia on 24-h urine composition in adults without urolithiasis. Lipids Health Dis. 2018;17:250.
Article CAS PubMed PubMed Central Google Scholar
Lee SC, Kim YJ, Kim TH, Yun SJ, Lee NK, Kim WJ. Impact of obesity in patients with urolithiasis and its prognostic usefulness in stone recurrence. J Urol. 2008;179:570–4.
Xu Z, Yao X, Duan C, Liu H, Xu H. Metabolic changes in kidney stone disease. Front Immunol. 2023;14:1142207.
Article CAS PubMed PubMed Central Google Scholar
Wilson PW. High-density lipoprotein, low-density lipoprotein and coronary artery disease. Am J Cardiol. 1990;66:A7-10.
Morvaridzadeh M, Zoubdane N, Heshmati J, Alami M, Berrougui H, Khalil A. High-density lipoprotein metabolism and function in cardiovascular diseases: what about aging and diet effects? Nutrients. 2024;16(5):653.
Article CAS PubMed PubMed Central Google Scholar
Tosheska Trajkovska K, Topuzovska S. High-density lipoprotein metabolism and reverse cholesterol transport: strategies for raising HDL cholesterol. Anatol J Cardiol. 2017;18:149–54.
Abdullah SM, Defina LF, Leonard D, Barlow CE, Radford NB, Willis BL, Rohatgi A, McGuire DK, de Lemos JA, Grundy SM, et al. Long-term association of low-density lipoprotein cholesterol with cardiovascular mortality in individuals at low 10-year risk of atherosclerotic cardiovascular disease. Circulation. 2018;138:2315–25.
Article CAS PubMed Google Scholar
Akin F, Altun I, Ayca B, Kose N, Altun I. Associations of non-HDL-C and triglyceride/HDL-C ratio with coronary plaque burden and plaque characteristics in young adults. Bosn J Basic Med Sci. 2022;22:1025–32.
Comments (0)